Arax Advisory Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.9K | Buy |
|
|||||
|
2025
Q1 | $23K | Sell |
|
|||||
|
2024
Q4 | $113K | Sell |
|
|||||
|
2024
Q3 | $133K | Buy |
|
|||||
|
2024
Q2 | $117K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $4.02K | Buy |
|
|||||
|
2023
Q3 | $1.42K | Buy |
|
|||||
|
2023
Q2 | $570 | Sell |
|
|||||
|
2023
Q1 | $1.6K | Hold |
|
|||||
|
2022
Q4 | $1.9K | Hold |
|
|||||
|
2022
Q3 | $2K | Buy |
|